A Phase I Trial to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer Vaccine, Adjuvanted

NCT03547245 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

NETWORK

Sponsor class

Conditions

HIV/AIDS

Interventions

BIOLOGICAL: eOD-GT8 60mer + AS01B/ DPBS sucrose/IM
BIOLOGICAL: eOD-GT8 60mer + AS01B/ DPBS sucrose/IM
BIOLOGICAL: DPBS Sucrose

Sponsor

International AIDS Vaccine Initiative